Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates.

Antimicrobial Agents and Chemotherapy
S M BlaneyF M Balis

Abstract

2'-Deoxy-3'-thiacytidine is a dideoxycytidine analog with a sulfur in place of the 3' carbon of the ribose. There are two enantiomeric forms of the compound, both of which inhibit human immunodeficiency virus type 1 and 2 replication in vitro. However, the (-) enantiomer (lamivudine) appears to be significantly less cytotoxic to uninfected lymphocytes than is the (+) enantiomer. Lamivudine has entered initial clinical trials, and the present study was designed to describe the pharmacokinetic behavior of this compound in both plasma and cerebrospinal fluid (CSF) of primates. Lamivudine was administered as an intravenous bolus dose of 20 mg/kg for 24 h for administration. Urine samples were also obtained from two animals. The same dose of the racemate (BCH-189) was administered to one animal. The drug was quantitated in CSF and plasma with a reverse-phase high-pressure liquid chromatography technique. Elimination of lamivudine from plasma was biexponential, with a mean alpha phase half-life of 5.4 min, a mean beta phase half-life of 84 min, and a total clearance of 6.1 liters/h. The total clearance of the same dose of BCH-189 in a single animal was 11.0 liters/h. In two animals from which urine was obtained for 12 h postadministr...Continue Reading

References

Dec 1, 1979·Computer Programs in Biomedicine·G D Knott

❮ Previous
Next ❯

Citations

Jul 19, 2000·Archives of Biochemistry and Biophysics·Q K HuynhT Dian
Jun 5, 2002·Biochimica Et Biophysica Acta·Sławomir Milewski
Nov 14, 1998·AIDS·R H EntingP Portegies
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·Raymond F SchinaziSusan Erickson-Viitanen
May 23, 2003·Antimicrobial Agents and Chemotherapy·Huachun ChenRaymond F Schinazi
Feb 12, 2013·Bioanalysis·Robin DiFrancescoGene D Morse
Sep 10, 2014·Clinical Pharmacokinetics·Andrea CalcagnoStefano Bonora
May 13, 2008·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Jiaping LaiZongwei Cai
Nov 17, 2004·Reviews in Medical Virology·Nathalie Strazielle, Jean-François Ghersi-Egea
Feb 5, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Hadi ManjiAlan Winston
Jun 17, 2004·American Journal of Veterinary Research·Weijiang ZhangStevenson M A McCrackin
Dec 22, 1999·Journal of Viral Hepatitis·T Shaw, S A Locarnini
Nov 2, 2016·Antimicrobial Agents and Chemotherapy·Paul CurleyMarco Siccardi
May 27, 2003·The Journal of Pharmacology and Experimental Therapeutics·J E GibbsS A Thomas
Mar 12, 2019·Drug Metabolism Letters·Liyue HuangZhiyang Zhao
Aug 31, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yoko NagayaYoshitane Nozaki
Mar 12, 2021·Advanced Drug Delivery Reviews·Ghazal Naseri KouzehgaraniDidier R Lefebvre
Apr 2, 1999·Antimicrobial Agents and Chemotherapy·L T MartinJ P Sommadossi
Mar 1, 1996·Antimicrobial Agents and Chemotherapy·P RajagopalanR F Schinazi
Jul 12, 2021·Advanced Drug Delivery Reviews·Amira Sayed HanafyAlf Lamprecht
May 1, 1997·Antimicrobial Agents and Chemotherapy·R NauH W Prange

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.